Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:chemicalFormula |
C22H24N2O5S
|
| gptkbp:clinicalTrials |
Phase II
|
| gptkbp:developedBy |
PharmaMar
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lurbinectedin
|
| gptkbp:isATypeOf |
100507-64-0
|
| gptkbp:lastProduced |
2020
|
| gptkbp:route |
intravenous
|
| gptkbp:sideEffect |
anemia
fatigue nausea vomiting diarrhea constipation alopecia neutropenia |
| gptkbp:triggerType |
inhibits_RNA_polymerase_II
|
| gptkbp:usedFor |
treatment of small cell lung cancer
|